JULY 2016 TABLE OF CONTENTS INTRODUCTION

First Page		Document Content
Date: 2016-07-28 12:58:50 Immunosuppressants Monoclonal antibodies Immunology Biotechnology Immune system TNF inhibitor Infliximab Tocilizumab Adalimumab Tumor necrosis factor alpha Natalizumab Etanercept		JULY 2016 TABLE OF CONTENTS INTRODUCTION Add to Reading List Source URL: www.abirisk.eu Download Document from Source Website File Size: 1,18 MB Share Document on Facebook

	UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol DocID: 1rakB - View Document
	JUNE 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qDC6 - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qs3R - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qius - View Document
	FEBRUARY 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qcKs - View Document